Abbott Laboratories

ABT

$125.83

+12.1% last 12 months

Polen Capital Holding value: $2.77 Billion Ken Fisher Holding value: $1.05 Billion Ray Dalio Holding value: $235 Million Jeremy Grantham Holding value: $221 Million Ken Griffin Holding value: $62.2 Million Jim Simons Holding value: $29.6 Million Joel Greenblatt Holding value: $8.08 Million Mario Gabelli Holding value: $3.01 Million Tom Russo Holding value: $1.54 Million Chuck Akre Holding value: $0 Tom Gayner Holding value: $0 Daniel Loeb Holding value: $0 Chris Davis Holding value: $0 Stanley Druckenmiller Holding value: $0 George Soros Holding value: $0 Bill Gates Holding value: $0 Donald Yacktman Holding value: $0 David Tepper Holding value: $0 Prem Watsa Holding value: $0

Market Cap

$221 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$104.19 - $142.10

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

30.44x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$1.81 (1.45%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $221 Billion
Enterprise Value $229 Billion
Dividend Yield $1.81 (1.45%)
1 Year Return +13.6%
52-Week High $142.10
52-Week Low $104.19
Beta 0.54
Outstanding Shares 1.77 Billion
Avg 30 Day Volume 5.55 Million

Valuation

P/E Ratio 30.44
PEG 43.21
Earnings per Share $4.04
Price to Sales Ratio 5.47
Price to Book Ratio 6.62
Revenue to Enterprise Value 5.42
EBIT to Enterprise Value 27.03
Total Debt to Enterprise Value 0.08
Debt to Equity 0.53

Profitability

Revenue $42.3 Billion
Gross Profit $24 Billion
EBIT $8.48 Billion
Net Income $7.24 Billion
Profit Margin 17.12%
Quarterly Earnings Growth (YoY) +70.5%
Return on Equity 21.04%
Return on Assets 9.82%
Return on Invested Capital 13.92%

Insider trades

No purchases

9,439 shares sold (1 transactions)

No purchases

135,925 shares sold (1 transactions)

No purchases

90,200 shares sold (5 transactions)

No purchases

No sells

Q2 2021 Q3 2021 Q4 2021 Q1 2022

About Abbott Laboratories

CEO: Robert Ford

Industry: Pharmaceutical Preparation Manufacturing

Similar stocks

Johnson & Johnson
Johnson & Johnson
Pfizer Inc.
Pfizer Inc.
Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
Hologic, Inc.
Hologic, Inc.
Medtronic Plc
Medtronic Plc
Boston Scientific Corp.
Boston Scientific Corp.
Astrazeneca plc - ADR
Astrazeneca plc - ADR
Novartis AG - ADR
Novartis AG - ADR
Glaxosmithkline plc - ADR
Glaxosmithkline plc - ADR

News

Raymond James Trust N.A. Sells 3,037 Shares of Abbott Laboratories (NYSE:ABT)

Raymond James Trust N.A. Sells 3,037 Shares of Abbott Laboratories (NYSE:ABT)

Raymond James Trust N.A. lessened its holdings in shares of Abbott Laboratories (NYSE:ABT) by 1.6% during the 3rd quarter, according to its most recent filin...

Transcript Daily Transcript Daily, about 2 months ago
Ventricular Assist Devices Market to grow by USD 4.05 billion from 2020 to 2025 | Evolving Opportunities with Abbott Laboratories & Abiomed Inc. | 17000+ Technavio Reports

Ventricular Assist Devices Market to grow by USD 4.05 billion from 2020 to 2025 | Evolving Opportunities with Abbott Laboratories & Abiomed Inc. | 17000+ Technavio Reports

NEW YORK, Nov. 29, 2021 /PRNewswire/ -- Technavio''s latest offering, the Ventricular Assist Devices Market report provides a detailed analysis of the compet...

PR Newswire PR Newswire, about 2 months ago
Blood Testing Market 2019: Association between Major Key Vendors Like Abbott Laboratories (U.S.) to Produce Promising Growth Opportunities in Upcoming Years, says Straits Research

Blood Testing Market 2019: Association between Major Key Vendors Like Abbott Laboratories (U.S.) to Produce Promising Growth Opportunities in Upcoming Years, says Straits Research

Blood Testing Market The global blood testing market was valued at USD 54.1212 billion in 2018 and is projected to reach a value of USD 67.50 billion by 2026...

OpenPR OpenPR, about 2 months ago
Lathrop Investment Management Corp Sells 100 Shares of Abbott Laboratories (NYSE:ABT)

Lathrop Investment Management Corp Sells 100 Shares of Abbott Laboratories (NYSE:ABT)

Lathrop Investment Management Corp lessened its stake in Abbott Laboratories (NYSE:ABT) by 2.3% in the third quarter, according to the company in its most re...

Transcript Daily Transcript Daily, about 2 months ago
Never miss a trade
To improve your user experience we use cookies.